Streetwise Articles By Production Types

Streetwise Nutraceuticals Articles

Yields Over 9% and Discounts Up to 22% Make for Buys

Contributed Opinion

Adrian Day for Streetwise Reports (12/10/2018)

Yields Over 9% and Discounts Up to 22% Make for Buys

Money manager Adrian Day looks at several non-resource companies in his portfolio, most with very attractive dividend yields as high as more than 9%. read more >

Three Small-Caps on This Fund Manager's List

Streetwise Reports (10/30/2018)

Steve Palmer, founding partner, President and Chief Investment Officer of AlphaNorth Asset Management, talks with Streetwise Reports about several small-cap companies from three sectors that he has been following. read more >

Update on Stock in Vanguard of Drive to Phase Out Antibiotics in Animal Feed

Contributed Opinion

Clive Maund for Streetwise Reports (10/29/2018)

Update on Stock in Vanguard of Drive to Phase Out Antibiotics in Animal Feed

Technical analyst Clive Maund provides an update on a company whose product is replacing antibiotics for growth promotion in animal feed. read more >

This Biotech, Whose Discovery Could End Routine Antibiotic Use in Livestock, Is the Pick of Three Fund Managers

Streetwise Reports (10/27/2018)

Multiple governments around the world have unleashed mandates on livestock feed regulations that pose an opportunity for a Canada-based biotech company. read more >

News Update

Animal Health Product Developer to Expand Sales Footprint

News Update

Streetwise Reports (10/20/2018)

Animal Health Product Developer to Expand Sales Footprint

This Canadian company makes progress with its commercial uptake efforts. read more >

Stock in Vanguard of Drive to Phase Out Antibiotics in Animal Feed

Contributed Opinion

Clive Maund for Streetwise Reports (10/01/2018)

Stock in Vanguard of Drive to Phase Out Antibiotics in Animal Feed

As the worldwide movement to ban antibiotics as a growth promoter in animal feed gains traction, technical analyst Clive Maund has called an "immediate strong buy" on a company that has developed an alternative. read more >

News Update